Navigation Links
New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
Date:5/30/2013

San Diego, CA (PRWEB) May 30, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and it is now actively providing expert opinion in view of the recent news on Granuflo Lawsuits.

According to court documents, on May 17, 2013 a daughter filed a lawsuit in Massachusetts District Court (case no. 1:2013cv11215) alleging that her mother suffered a fatal cardiac arrest caused by Granuflo and Naturalyte dialysis treatments. Granuflo, manufactured by Fresenius Medical Care, is an additive used in kidney dialysis to help patients maintain their bicarbonate levels which neutralize the acid buildup in the bloodstream during dialysis.

On April 23, 2013 the children of a woman filed a lawsuit in Louisiana Western District Court (case no. 5:2013cv00829) alleging that their mother died as a result of using Granuflo and NaturaLyte. In the lawsuit plaintiffs claim that, during hemodialysis at a Fresenius medical center, their mother suffered a cardiac event and she died of a heart attack a few hours later.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Granuflo severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Granuflo lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Court data updated on May 14, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), indicate that there are 161 actions pending in the Granuflo/Naturalyte MDL (MDL 2428, U.S. District Court for the District of Massachusetts). All the actions in the MDL involve similar allegations that plaintiffs suffered injury or death caused by the use of GranuFlo and/or NaturaLyte during hemodialysis, which allegedly may cause metabolic alkalosis in patients resulting in low blood pressure, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest.

AttorneyOne.com has further information on Granuflo lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/5/prweb10773984.htm

Read the full story at http://www.prweb.com/releases/2013/5/prweb10783818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
5. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
6. Grant funds cardiac stem cell research for Duchenne muscular dystrophy-related heart disease
7. Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles
8. Study suggests new role for ECMO in treating patients with cardiac arrest and profound shock
9. Estrogen Levels Tied to Risk for Sudden Cardiac Death in Study
10. Study finds survival from cardiac arrest highest in the operating room or post-anesthesia care unit
11. Common Heart Meds May Boost Recovery From Non-Cardiac Surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 24, 2017 , ... Digital Scientists, a software innovation lab specializing in web ... Greenville, South Carolina location. The lab has set up shop at the ... working with South Carolina clients for years from our office here in Atlanta,” explains ...
(Date:3/24/2017)... ... 2017 , ... According to a new study by NCPA Senior Fellow John ... the rules Congress has directed the CBO to follow. The CBO itself previously recognized ... Yet, it estimates a reduction in employer-based coverage due to the GOP reform, which ...
(Date:3/24/2017)... ... 24, 2017 , ... The iaedp Foundation, the premier provider of educational programs ... suffering from the full spectrum of disordered eating, announced today that the 2017 Symposium ... all 50 states and several countries converged on the Green Valley Resort in Las ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred ... 2017. This sacred and spiritual journey during the Summer Solstice will also ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Today Stock-Callers.com have issued research ... Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences ... SSH ). These companies are part of the Healthcare sector, ... March 23 rd , 2017, with the NYSE Health Care ... care companies in the S&P 500 were down about 0.4% ...
(Date:3/24/2017)... INDIANAPOLIS , March 24, 2017  Eli ... today announced plans to invest $850 million in ... span facilities across its U.S. enterprise, including research ... The investments are being driven by demand for ... of potential medicines in development targeting cancer, pain, ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: